In: Supportive Care in Cancer, 2015, vol. 23, no. 2, p. 525-545
|
In: Journal of Infectious Diseases, ///-
|
In: Clinical Oral Investigations, 2015, vol. 19, no. 7, p. 1581-1593
|
In: Annals of Surgical Oncology, 2015, vol. 22, no. 9, p. 3109-3120
|
In: EMBO molecular medicine, 2016, vol. 8, no. 4, p. 407-421
Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG. In this study, we identified two broadly neutralizing human monoclonal antibodies that represent a...
|
In: Plos pathogens, 2013, vol. 9, no. 11, p. e1003776
The mechanisms by which human immunodeficiency virus type 1 (HIV-1) crosses mucosal surfaces to establish infection are unknown. Acidic genital secretions of HIV-1-infected women contain HIV-1 likely coated by antibody. We found that the combination of acidic pH and Env- specific IgG, including that from cervicovaginal and seminal fluids of HIV-1-infected individuals, augmented transcytosis...
|
In: Animal Cognition, 2010, vol. 13, no. 1, p. 1-19
|
In: Review of Managerial Science, 2009, vol. 3, no. 2, p. 75-116
|
In: European Journal of Clinical Microbiology and Infectious Diseases, 1997, vol. 16, no. 9, p. 675-677
|
In: Infection, 2006, vol. 34, no. 3, p. 163-168
|